Drug Information Department

Helen Ndagije - Head Drug Information

The Drug Information Department ensures that all stakeholders, pharmaceutical service providers and the general public receive the right information on medicines.

The department also ensures that drug promotional materials are vetted, approved and monitored to ensure that misleading, biased and inaccurate information on medicines is not disseminated. The department is also responsible for pharmacovigilance programs, adverse drug reactions reporting and clinical trials monitoring.

The department hosts the National Pharmacovigilance Centre.